Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology

Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel

Incedo Announces the Formation of Its Life Sciences and Healthcare Strategic Advisory Board

Context Therapeutics Appoint Dr. Claudio Dansky Ullmann as CMO and Karen Andreas as VP, Clinical Operations

Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Incyte Reports 2024 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

Merck Announces Second-Quarter 2024 Financial Results

HOPE Therapeutics and NRx Pharmaceuticals Announce Arbitration Order Enabling HOPE Therapeutics Spinoff

HOPE Therapeutics and NRx Pharmaceuticals Announce Alignment with FDA on Pediatric Study Plan for NRX-100

Kendra Bracken-Ferguson Appointed CEO of Carmell Corp.

States With the Best & Worst Health Care in 2024 – WalletHub Study

Bristol Myers Squibb Reports Second Quarter Financial Results for 2024

KORU Medical Systems Promotes Christopher Pazdan to Chief Operating Officer

HealthTech Firm Loyal Raises $33.5 Million from Concord Health, Others

Dr. Eric Sandler Appointed As Chair Of New Jersey Speech And Hearing Association Audiology Committee

Citi Impact Fund-backed Vitable Health Closes $16 Million Series A